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In 151 patients experiencing acute myocardial infarc-
tion, emergency coronary angioplasty was performed as
primary therapy. Overall, angioplasty was successful in
132 patients (87%); it was successful in 91 (85%) of 107
patients with a totally occluded infarct-related artery
and in 41 (93%) of 44 patients with a subtotally occluded
infarct-related artery. After successful angioplasty, mean
residual stenosis was 29% (range 0 to 70). Eighteen pa-
tients were in cardiogenic shock (12%) including four
patients receiving cardiopulmonary resuscitation during
the angioplasty procedure. Hospital mortality was 9%,
with 7 of 13 deaths occurring in patients presenting with
cardiogenic shock or intractable ventricular arrhythmia.
Hospital mortality was 5% in patients with successful
angioplasty versus 37% in those with unsuccessful an-
gioplasty (p < 0.001).
In the immediate period after angioplasty, left ven-
tricular ejection fraction was significantly lower for pa-
tients with lesions of the left anterior descending artery
(34 ± 10%) than for patients with lesions of the left
circumflex or right coronary artery (43 ± 11%). In
Recent therapy for myocardial infarction has been directed
toward salvage of ischemic myocardium. Thrombolytic agents
such as streptokinase (1,2), urokinase (3) and tissue-type
plasminogen activator (4) have been used to restore blood
flow to ischemic tissue. Whereas some studies (5,6) have
shown that successful thrombolytic therapy may favorably
affect prognosis, improvement in left ventricular function
has been more difficult to demonstrate (7-13).
Intravenous or intracoronary thrombolytic therapy may
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patients with successful angioplasty, significant improve-
ment in left ventricular ejection fraction averaged 13 ±
12% (p < 0.001) for those with lesions ofthe left anterior
descending artery and 10 ± 12% (p < 0.001) for those
with lesions of the left circumflex or right coronary ar-
tery.
Repeat coronary angiography was performed in 85
(70%) of 121 patients who had successful angioplasty.
and survived hospitalization without requiring bypass
surgery; restenosis was found in 26 (31%), and angio-
plasty was repeated in 22 patients, successfully in each.
Reocclusionwas found in eight patients (9%), all of whom
were treated medically. Posthospital cardiac mortality
was 2% during an average follow-up of 20 months (range
6 to 43); all three late deaths were due to severe left
ventricular dysfunction. Therefore, successful emer-
gency coronary angioplasty for acute myocardial in-
farction appears to salvage ischemic myocardium and
to result in a low hospital and follow-up mortality rate.
(1 Am Coll Cardiol1987; 10:264-72)
result in rapid restoration of blood flow due to clot lysis,
but does not improve the underlying vessel stenosis that is
usually present (2,8,14-20). Angioplasty, when successful,
not only results in prompt restoration of blood flow to isch-
emic myocardium, but usually alleviates underlying critical
vessel stenosis and achieves a residual narrowing of <50%
(15-20). In an initial pilot study (21) at our institution com-
paring intracoronary streptokinase with primary angioplasty
therapy, patients treated with angioplasty had a higher suc-
cessful recanalization rate, a significantly lower mean vessel
stenosis and a lower morbidity and mortality than did strep-
tokinase-treated patients. On the basis of these preliminary
data, the present longitudinal study was performed to in-
vestigate the efficacy of emergency angioplasty as primary
therapy for acute myocardial infarction. If the infarct-related
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artery could be recanalized quickly enough and if adequate
blood flow could be restored to ischemic heart muscle, then
significant salvage of myocardium should be demonstrable.
If significant reperfusion can be achieved by emergency
angioplasty, then morbidity and mortality after acute myo-
cardial infarction should be reduced by this therapy. The
decision was made to use angioplasty alone, rather than
angioplasty in conjunction with thrombolytic therapy, to
avoid the side effects of thrombolytic therapy such as hy-
potension (22), hemorrhage into ischemic myocardium (23)
and noncardiac bleeding complications that might adversely
affect patient survival and heart muscle salvage.
Methods
Study patients. Emergency percutaneous transluminal
coronary angioplasty was evaluated as primary therapy for
acute myocardial infarction in 151 patients at this institution
between December I, 1982 and January I, 1986. Criteria
for inclusion in the study were: I) presence of chest pain
consistent with acute myocardial ischemia; 2) electrocar-
diographic evidence of acute myocardial infarction as in-
dicated by at least I mm of ST elevation in two contiguous
leads or I mm of ST depression believed to represent re-
ciprocal changes to an area of infarction; 3) angiographic
demonstration of subtotal or total occlusion of the infarct-
related coronary artery; and 4) postangioplasty confirmation
of myocardial infarction by elevated serum creatine kinase
(CK) and cardiac isoenzyme fraction. No patient was ex-
cluded from the study because of age, cardiogenic shock or
prolonged cardiopulmonary resuscitation. Cardiogenic shock
was defined as systolic blood pressure <85 mm Hg unre-
sponsive to volume expansion and requiring pressor or in-
traaortic balloon therapy.
Angioplasty protocol. In the emergency room or coro-
nary care unit, each patient received sublingual or intra-
venous nitrate and calcium channel antagonist therapy. The
patient was then immediately transferred to the cardiac cath-
eterization laboratory. A cardiologist experienced in angio-
plasty (D.A.R., TJ.L. or RJ.L.) and a cardiac catheter-
ization laboratory team were on call 24 hours a day. In the
cardiac catheterization laboratory, sheaths were placed in
the femoral artery and vein. The patient was given 10.000
units of heparin intravenously and was started on a pro-
phylactic intravenous Xylocaine (lidocaine) infusion. Fur-
ther nitrate and calcium antagonist therapy was administered
if systolic blood pressure was > llO mm Hg; intravenous
morphine was used for chest pain. In patients experiencing
cardiogenic shock or receiving cardiopulmonary resuscita-
tion, coronary angiography and balloon angioplasty were
performed concurrently with vasopressor therapy or in-
traaortic balloon counterpulsation.
Coronary angiography of the artery that was thought to
be infarct related was performed first. followed by angi-
ography of the uninvolved vessel. A member of the cath-
eterization laboratory team was able to set up the angioplasty
equipment while the cardiologist performed angiography of
the uninvolved artery. Coronary angioplasty was performed
with a USCI (Bard) guiding catheter and with a USCI or
ACS (Lilly) steerable balloon catheter system. Initially. a
0.014 inch (0.036 em) steerable guide wire was used to
recanalize the lesion. The balloon was then advanced across
the occlusion and inflated to 5 to 7 atm. Higher inflation
pressures were used, if necessary, to eliminate balloon in-
dentation by a lesion. Inflation time was approximately 30
seconds. If blood flow was restored. the balloon was gen-
erally reinflated several times. Three to five minutes were
allowed between inflations so that perfusion of the ischemic
myocardium could occur in the interim. In many cases,
thrombus was present proximal to the actual coronary artery
stenosis and. in some cases, there were additional distal
lesions requiring dilation.
The primary goal of angioplasty was the prompt resto-
ration of blood flow to the ischemic region. In all cases, an
attempt was made to restore the vessel to a normal diameter
or at least to achieve a residual stenosis of <50% by visual
estimate. If, after several balloon inflations, significant nar-
rowing was still present, the lesion was usually recrossed
with a larger balloon. If a large intimal dissection or sig-
nificant residual thrombus appeared to be present. then ad-
ditional inflations of I to 2 minutes' duration were performed
in an attempt to maintain patency of the vessel. In seven
cases in which there was an obvious thrombus or a hazy
appearance of the vessel and slow flow apparently due to
thrombus. 25,000 to 100,000 units of intracoronary uro-
kinase or streptokinase were given. If blood flow was re-
stored to the myocardium but vessel patency could not be
maintained. and if bypass surgery was recommended and
available. then the guide wire or a perfusion catheter was
left in place across the lesion while the patient was trans-
ferred to surgery.
Postangioplasty protocol. After angioplasty, left ven-
triculography was performed if the patient had a stable car-
diac rhythm and a systolic blood pressure> 110 mm Hg.
Each patient who did not require emergency bypass surgery
was transferred to the coronary care unit with the sheaths
left in the femoral artery and vein. Heparin was continued
for a minimum of 48 hours. When significant thrombus
appeared to be present at the site of the lesion. heparin
infusion was continued for up to 96 hours. Intravenous
nitroglycerin was continued for 24 to 48 hours if the patient's
systolic blood pressure remained > 110 mm Hg. Pressor
therapy was administered. if necessary. to maintain a sys-
tolic blood pressure of 2110 mm Hg, to ensure adequate
perfusion of the recanalized coronary artery. Hemodynamic
monitoring through a Swan-Ganz catheter was performed
in most patients for at least 24 hours. A temporary pace-
maker was placed only when clinically indicated. When
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Table 1. Clinical Characteristics of lSI Patients
Before Angioplasty
possible, total CK and isoenzymes were obtained before
angioplasty, immediately on returning to the coronary care
unit after angioplasty and every 4 hours thereafter for a
minimum of 36 hours. After portable radionuclide scanning
became available in 1985, ejection fraction determination
was performed within 24 hours after infarction and at follow-
up no earlier than I week after infarction.
Follow-up. Immediately after angioplasty and continu-
ing for 6 months, each patient received acetylsalicyclic acid
(325 mg), dipyridamole (150 mg) and oral calcium channel
Characteristic
Male (n)
Age (yr) (mean; range)
Duration of chest pain to angioplasty
(mean hours; range)
Diagnosis of infarction by ECG to angioplasty
:52 hours (n)
CK before angioplasty
:5232 IV/liter (normal) (n)
232 to 1,000 IV/liter (n)
> I ,000 IV/liter (n)
Not done (n)
Infarct-related coronary artery
Left anterior descending (n)
Right (n)
Left circumflex (n)
Extent of disease
Single vessel (n)
Double vessel (n)
Triple vessel (n)
Cardiogenic shock (n)
ECG = electrocardiogram; n = no. of patients.
123 (81%)
56; 29 to 75
3.1; 0.5 to 8.0
137 (91%)
116 (77%)
26 (17%)
5 (3%)
4 (3%)
70 (46%)
58 (39%)
23 (15%)
68 (45%)
47 (31%)
36 (24%)
18 (12%)
antagonist therapy daily. In patients who consented, repeat
cardiac catheterization was performed 3 to 6 months after
angioplasty, unless symptoms suggestive of ischemia war-
ranted earlier restudy. Left ventriculograms were done in
the 30° right anterior oblique projection and ejection fraction
was calculated by the area-length method of Sandler and
Dodge (24). Average percent coronary artery stenosis was
calculated from the percent diameter stenosis of at least two
orthogonal coronary angiogram projections. Stenosis >50%
in two projections was considered significant coronary artery
disease. Each patient had clinical follow -up information
available through July I, 1986. Mean follow-up was 20
months (range 6 to 43).
Statistics. The numerical results are expressed as mean
values ± SD. Statistical analysis from group means and
mean differences were performed by the two-tailed Stu-
dent's t test.
Results
Clinical characteristics of the 151 patients (Table 1).
Chest pain duration before angioplasty was determined from
the time chest pain was of sufficient severity to cause the
patient to seek medical attention. The mean duration of chest
pain before angioplasty was 3.1 hours (range 0.5 to 8.0).
Successful angioplasty of the infarct-related artery was ac-
complished within 2 hours of electrocardiographic (ECG)
diagnosis of acute myocardial infarction in 137 patients
(91%). Before angioplasty, 18 patients (12%) were in car-
diogenic shock, including 4 patients receiving cardiopul-
monary resuscitation.
Angioplasty success rate (Table 2). Before angioplasty,
107 (71%) of the 151 patients had total occlusion of the
Table 2. Results of Emergency Angioplasty for Acute Myocardial Infarction in lSI Patients
Patients
Left anterior descending artery
Total occlusion
Subtotal occlusion
Both
Right coronary artery
Total occlusion
Subtotal occlusion
Both
Left circumflex artery
Total occlusion
Subtotal occlusion
Both
All vessels
Total occlusion
Subtotal occlusion
Both
Total No.
50
20
70
43
15
58
14
9
23
107
44
151
No. With Successful
Angioplasty (%)
44 (88)
20 (100)
64 (91)
35 (81)
12 (80)
47 (81)
12 (86)
9 (100)
21 (91)
91 (85)
41 (93)
132 (87)
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Table 3. Mortality Statistics
*Four patients (two patients each in the groups with and without suc-
cessful angioplasty) were receiving cardiopulmonary resuscitation at the
time of angioplasty.
infarct-related artery and 44 (29%) had subtotal occlusion
of 90 to 99%, with slow anterograde flow. Angioplasty
success is defined as reestablishment or improvement of
anterograde flow in the infarct-relatedartery associated with
a residual stenosis of ::;70%. Overall, angioplasty success
rate was 87%, with a success rate of 85% in patients with
a totally occluded infarct-relatedartery and 93% in patients
with a subtotally occluded infarct-related artery. In patients
with successful angioplasty, mean residual stenosis was 29%
(range 0 to 70).
There was no significant difference in angioplastysuccess
rate between patients who had a chest pain duration ::;3
hours and those with >3 hours of chest pain before at-
tempted angioplasty. Also, there was no significant differ-
ence in angioplasty success rate between patients who had
a normal serum CK and those who had an elevated CK
before angioplasty.
Hospital mortality and morbidity (Table 3). Overall
hospital mortality was 9%. Nine (69%) of the 13 hospital
Hospital deaths (n = 151)
Successful angioplasty (n = 132)
Cardiogenic shock
Ventricular arrhythmia
Second vessel angioplasty
Unsuccessful angioplasty (n = 19)
Cardiogenic shock
Ventricular arrhythmia
Infarct extension
Cardiac rupture
Pulmonary embolism
Posthospital deaths (n = 138)
Successful angioplasty (n = 126)
Heart failure
Unsuccessful angioplasty (n = 12)
All deaths (n = 151)
Deaths/Total
Patients (%)
13 (9)
6* (5)
4
I
I
7* (37)
3
I
I
I
I
3 (2)
3 (2)
3
o (()
16 (II)
deaths occurred in patients with either cardiogenic shock or
refractory ventricular tachycardia or fibrillation. All four
patients who were receiving cardiopulmonary resuscitation
during angioplasty died, even though two of these patients
had successful recanalization of the infarct-related artery.
Of the 18 patients presenting in cardiogenic shock, 12 had
a left anterior descending lesion and 6 had a left circumflex
or right coronary artery lesion. Seven (39%) of the 18 pa-
tients died during their hospitalization, 5 with anterior in-
farction and 2 with inferior infarction.
Hospital mortality was 5% for patients who had suc-
cessful angioplasty as compared with 37% for patients with
unsuccessful angioplasty (p < 0.00 I). Late hospital death
due to infarct extension, cardiac rupture and pulmonary
embolism occurred only in patients with unsuccessful an-
gioplasty. Hospital mortalitywas 6% for patients with single
and double vessel disease and 17% for patients with triple
vessel disease. The higher mortality associated with triple
vessel disease was due exclusively to a higher incidence of
cardiogenic shock in these patients.
Recurrent ischemia during hospitalization occurred in 7
(5%) of 132 patients with successful angioplasty. Five pa-
tients had ischemia involvingthe infarct-relatedartery. Two
of these five had repeat catheterization with angiographic
evidence of total vessel occlusion and they underwent suc-
cessful repeat angioplasty without infarction; the other three
had infarct extension by ECG and cardiac enzyme criteria.
Two additional patients had ischemia due to significantdis-
ease in vessels other than the infarct-related artery; both
underwent coronary bypass grafting during their hospital-
ization. Of the 12 patients with unsuccessful angioplasty
who survived hospitalization, 3 had recurrent ischemia in
the hospital and underwent bypass surgery for multiple ves-
sel disease.
Improvement in left ventricular function (Table 4).
After successfulangioplasty, immediateand follow-up ejec-
tion fraction determinations by serial cineangiographic or
nuclear studies were available for 98 (81 %) of the 121
patients who survived hospitalization and did not require
coronary bypass grafting during their hospitalization. Be-
cause there was no significantdifference in ejection fraction
Table 4. Ejection Fraction Data for 98 Patients After Successful Angioplasty
Infarct-Related Artery
Ejection fraction (%)
Immediate
Follow-up
Mean change
Patients with >5% increase in
ejection fraction (%)
*Mean ± SD; tp < 0.001.
Left Anterior Descending
Coronary Artery
(n = 45)
34 ± 10*
47 ± 15
+ 13 ± 12t
67
Left Circumflex or
Right Coronary Artery
(n = 53)
43 ± II
53 ± to
+ 10 ± 12t
oX
p Value
<0.001
<0.01
NS
NS
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data between patients with a left circumflexor right coronary
artery lesion, these patients were considered together. Pa-
tients with a left anterior descending artery lesion had a
significantly lower mean immediate and follow-up ejection
fraction than did patients with a circumflex or right coronary
artery lesion. Mean improvement in ejection fraction was
highly significant (p < 0.00 I) , both for patients with a left
anterior descending artery lesion (+ 13 ± 12%) and for
patients with a circumflex or right coronary artery lesion
(+ 10 ± 12%). Ifan improvement in ejection fraction 2:5%
is considered a significant change (20),then 30 (67%) of 45
patients with a left anterior descending artery lesion and 36
(68%) of 53 patients with a circumflex or right coronary
artery lesion demonstrated a significant improvement in
ejection fraction at follow-up study.
Recovery of left ventricular function was analyzed spe-
cifically in relation to the status of the infarct-related artery
at follow-up angiography (Fig . 1). Sixty-seven patients had
immediate and follow-up cineangiography and left ventric-
ulography. This group included 59 patients with a patent
infarct-related artery at follow-up and 8 patients with an
initially successful angioplasty who had a totally occluded
infarct-related artery at follow-up. For patients with a left
anterior descending artery lesion, ejection fraction improved
from 37 ± I I% in the immediate period to 54 ± II % at
follow-up. This represented a 17 ± 9% (p < 0.001) im-
provement, with 25 (83%) of 30 patients demonstrating an
improvement of 2:5% in ejection fraction. For patients with
a left circumflex or right coronary artery lesion, ejection
fraction improved from 46 ± 10% acutely to 56 ± 8% at
follow-up;average improvement was 10 ± I I%(p < 0.00 I),
and 20 (69%) of 29 patients had an improvement of 2:5%
in ejection fraction. The improvement in ejection fraction
was significantly greater (p < 0.00 I ) for patients with left
anterior descending than for patients with a left circumflex
or right coronary artery lesion. Restenosis, in the absence
of reocclusion, did not adversely affect recovery of left
ventricular function.
In patients with a totally occluded infarci-related artery
at follow-up, no significant improvement in left ventricular
function was noted. However, three of eight patients had
an improvement 2:5% in ejection fraction.
When ejection fraction data for patients with a chest pain
duratio n :::;3 and >3 hours before successful recanalization
were compared, there was no significant difference in im-
provement at follow-up. However, the majority of patients
with chest pain duration > 3 hours had subtotal vessel oc-
clusion at the time of angioplasty, and possibly these patients
had more salvageable ischemic myocardium than would be
expected after total vessel occlusion for a similar period.
Follow-up morbidity an d mortality (Fig. 2). Mean
follow-up of the 132 patients with successful angioplasty
was 20 months (range 6 to 43). During the immediate hos-
pitalization, six patients died and five patients underwent
coronary bypass grafting. Of the 121 patients who left the
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Figure 1. Absolute change in ejection fraction (EF) comparing
the cineangiographic ejection fraction at the time of eme rgency
angioplasty with follow-up ejection fraction at repeat catheteriza-
tion in 67 patients . Mean value ± SE is shown . An increase in
ejection fraction of at least 5 percentage points (dashed line) is
considered clinically significant (20) .
hospital after being treated with angioplasty alone, 85 (70%)
underwent repeat cardiac catheterization. Significant reste-
nosis, defined as a lesion > 50%, was noted in 34 patients
(40%). Eight of the 34 had total occlusion of the infarct-
related artery and the remaining 26 patients had SIgnificant
restenosis with a persistently patent vessel. Repeat angio-
plasty was attempted in 22 patients with restenosis and was
successful in all of them, although one patient did eventually
have coronary bypass surgery. Of the 51 patients (60%)
who did not have significant restenosis at repeat angiogra-
phy, 8 had subsequent angioplasty of another vessel. Only
8 (9%) of the 85 patients with initially successful angioplasty
underwent coronary bypass grafting during follow-up-four
because of restenosis of the infarct-related artery and four
because of multivessel coronary disease.
Angiography was not repeated in 36 (30%) patients with
successful angioplasty . However, 26 of these patients had
thallium perfusion stress testing with the following results:
5 patients had normal rest/exercise thallium scans with no
evidence of infarction, 20 had evidence of scar only and 1
had evidence of scar plus ischemia.
The posthospital cardiac mortality rate was 2% (Table
3). All three cardiac deaths were due to severe left ventri-
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Figure 2. Flow chart of follow-upre-
sults of successfulpercutaneoustrans-
luminal angioplasty (PTCA) in 132
patients. CABG = coronary artery
bypass grafting; Rx = treatment.*One
late cardiac death.
Medical
Rx
8
Hospito I
Mortality
6
Medical
Rx
1
catheteri zation
85~
Restenosis ~50%\ OCclusion
26 8
/1 I
Repeat Elect i ve
P1CA CAH;
22 3
Successful P~ Patients
132
Rx-------:pL~
5
Medical
121
No repeat
catheteri zat ion
36*
Repeat
/
No restenosis >50%
/5~
Second vessel Elective Medical
P1Q\ om:; Rx
8 4'. 39*
cular dysfunction in patients who had acute anteroseptal
myocardial infarction, successful left anterior descending
angioplasty, multi vessel coronary disease and an ejection
fraction <20% at the time of hospital discharge. There were
no sudden deaths.
Four patients experienced myocardial infarction during
the follow-up period, In only one patient was the infarction
due to reocclusion of the infarct-related artery; this patient
experienced an inferior subendocardial infarction 2 weeks
after discharge. In the other three patients, myocardial in-
farction occurred >6 months after discharge and involved
a different vessel that did not have a significant stenosis on
initial angiography. Of the latter patients, two had successful
angioplasty and the other required emergency bypass sur-
gery after thrombotic reocclusion during angioplasty.
Of the 12 patients with unsuccessful emergency angio-
plasty, 3 had bypass surgery for recurrent ischemia during
their hospitalization. Two patients had bypass surgery dur-
ing follow-up, and one of these patients also required mitral
valve replacement for severe papillary muscle dysfunction.
Seven patients have maintained a stable condition on med-
ical therapy.
Discussion
Recovery of ischemic myocardium after recanalization
appears to be dependent on the following factors: duration
of ischemia before recanalization, adequacy of reperfusion
and incidence of vessel reocclusion after recanalization, Our
study shows that in patients with an acute myocardial in-
farction, emergency angioplasty is highly effective in rap-
idly restoring adequate blood flow to ischemic myocardium
and results in a low rate of reocclusion and reinfarction,
Significant improvement in left ventricular function was
found in patients whose infarct-related artery remained pat-
ent at follow -up angiography,
Reperfusion success rate. For the entire group of 151
patients, the emergency angioplasty success rate was 87%,
which is similar to the highest reported rates in other smaller
series of patients (15-20). After angioplasty, several pa-
tients had either significant residual thrombus or reaccu-
mulation of thrombus resulting in reduced blood flow. These
patients usually responded to repeat dilation of the lesion
by multiple, often prolonged (60 to 120 seconds) balloon
inflations. Only seven patients who were not hemodynam-
ically unstable required intracoronary thrombolytic drugs to
maintain vessel patency. However, in patients undergoing
cardiopulmonary resuscitation or refractory cardiogenic shock,
vessel patency often could not be maintained with angio-
plasty alone. Thus, adequate coronary perfusion pressure is
important in maintaining patency of the dilated vessel.
Rapid restoration of blood flow. The duration of isch-
emia before restoration of blood flow is an essential deter-
minant of the amount of irreversible muscle damage that
results from acute myocardial infarction. Reimer et al. (25)
demonstrated in dogs that myocardial necrosis began within
30 minutes of the onset of profound ischemia. Cell death
progressed rapidly in a . 'wave front" from the endocardium
to the epicardium. Forty minutes of ischemia resulted in
irreversible damage to approximately 50% of jeopardized
myocardium, and 3 hours of occlusion resulted in irrevers-
ible damage to approximately 67% of jeopardized myocar-
dium. Also using the canine model, Ellis et al. (26) occluded
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a coro nary artery for 2 hours and then allowed reperfusion.
Salvage of 40% of ischemic myocard ium was necessary to
permit significant recovery of myocardial contractility as
measured by echocardiography.
In previous clinical studies (7-11 ) improvement in ejec-
tion fraction was noted in patients who received thrombo-
lytic therapy within 2 hours of the onset of chest pain and
in whom there was succe ssful recanalization of the infarct-
related artery. Studies of pat ients who recei ved thrombol ytic
therapy > 3 hours after the onset of chest pain did not find
significant reco very of myocardial function, desp ite rees-
tablishment of blood flow (12,13 ).
In our study, the average time from onset of severe chest
pain to successful angioplasty reperfusion was 3.1 hours.
However , two-thirds of our patients had angioplasty per-
formed :53 hours after the onset of chest pain . Serum CK
was normal before angioplasty in 80% of patients with chest
pain :53 hours ' duration and in 60% of patients with chest
pain > 3 hours' duration. Therefore , despite the wide range
of chest pain duration , the majority of our patients had not
experienced ischemia of sufficient intensity and durati on to
result in detectable CK release into the bloodstream at the
time they were transported to the cardiac catheterization
laboratory. Neve rtheless , ischemia was present for a suf-
ficient period of time to produ ce heart muscle dama ge in
all patients , as evidenced by an elevated CK and cardiac
isoenzyme fraction in the postangioplasty blood samples of
all patients.
Adequacy of myocardial reperfusion. In our study,
mean residual stenosis after successful angioplasty was 29%,
with 97% of patients having a residual stenosis :550 %.
Adequate reperfusion may be essential to achieve myo-
cardial salvage . Sheehan et al. (8), in a study of patient s
with acute myocardial infarction and intracoronary strep-
tokinase reperfusion, noted that those with a posttreatment
minimal vesse l diameter < 0 .4 mm failed to show improve-
ment in regional wall motion , whereas those with a minimal
vessel diameter > 0 .4 mm demo nstrated a significant im-
provement in regional wall motion . In a study by Topol et
al. ( 19) of pat ients with acute myocardial infarction who
had successful recanalization with tissue-type plasminogen
activator but significant residual stenosis, echoc ardiography
revealed significant region al wall motion improvement in
those patients who underwent angioplasty but not in those
treated with thrombolytic therapy alone . Also , in a random -
ized trial of intracoron ary stre ptoki nase versus angioplasty
in acute myocardial infarction, O 'N eill et al. (20) found
that immediate recanalization rates were similar (83%) in
both treatment groups. However , residual stenosis was only
40% in the angioplasty group, but was 83% in the strep-
tokinase group. Left ventr icular eject ion fraction improved
significantly by 8% in the angioplasty group but did not
improve in the group treated with streptokinase alone.
In our study, ejection fraction improved by an average
of 13% in patients with successful left anterior descendin g
artery angioplasty and 10% in patients with success ful left
circumflex or right coronary artery angioplasty. Ejection
fraction improvement after successful angioplasty was con-
siderably greater than the 3 to 6% improvement in ejection
fract ion noted in three large series of patients recei ving
streptokinase therapy (6, 11 ,27). However. in patients with
success ful left anterior descend ing artery angioplasty and a
patent infarct-related artery at follow-up angiography, the
improvement in eject ion fraction was quite dramatic at 17%.
Interestingly, patients who experienced restenosis but per-
sistent patency of the infarct-related artery at follow-up had
improvement in left ventricular function indistinguishable
from that of patients with a widely patent vessel at restudy.
This observation suggests that restenosis occurs slowly enough
to permit recovery of profoundly ischemic myocardium .
Also , a high incidence of recurrent angina was found in
patients with restenosis, sugges ting that viable myocardium
was supplied by the stenotic vessel.
On the other hand. patients with a reoccluded artery at
fo llow-up fa iled to show a significant improvement in left
ventricular ejection fraction. However , closure of the in-
farct-related artery durin g follow-up was associated with
rcinfarction in only one case. The lack of symptoms related
to vessel reocclu sion durin g the follow-up period implies
that either there was no significant viable myocardium at
the time of closure , or that , before reocclusion, an adequate
number of collateral vessels had developed to prevent rein-
farction . Some patient s in this group did show improvement
in eject ion fraction 2:5% . These pat ients may have had
adequate initial reperfu sion to allow myocardial salvage and
then developed collateral flow before vessel reocclusion .
Mortality. Our overall hospital mortality rate was 9%.
Our series included patients in cardiogenic shock, patients
who had received or were receiving cardiopulmonary re-
susci tation at the time of angioplasty and patients>70 years
old . Because of the immedi ate transfer of patients from the
emergency room to the cardiac catheterization laboratory,
patients who otherw ise would have died within minutes of
arrival at the hospital survived long enough to be includ ed
in our study . In fact , all four patient s in our series who were
receiving cardiopulmonary resuscitation during the angio -
plasty procedure died in the cardiac catheterization labo-
ratory, even though two of these patient s had succe ssful
recanalization of the infarct-related artery . The se four pa-
tients would not have been considered candidates for strep-
tokinase therap y (6,27 ,28) . Exclud ing these four patients ,
our hospital mortality rate was 6% (9 of 147 patients).
For the 132 patients in whom acute angioplasty was
successful, the mortality rate was 5% . Howe ver , if the two
patients receiving cardiopulmonary resuscitation are ex-
cluded, then the mortality rate with successful angioplasty
is only 3%. Therefore, our mortality rate for patients with
successful angioplasty is comparable with or slightly lower
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than the 5 to 6% hospital mortality rate reported for patients
with successful recanalization in three large streptokinase
treatment studies (6,27,28). In contrast, the mortality rate
for the 19 patients with unsuccessful angioplasty was 37%.
Our mortality rate is higher than the 7 to 15% mortality rate
for patients with unsuccessful streptokinase treatment
(6,27 .28). All four patients in cardiogenic shock or refrac-
tory ventricular tachycardia or fibrillation died. Of the re-
maining 15 patients, 3 (20%) died from late hospital com-
plications of their myocardial infarction. Because the patients
with unsuccessful angioplasty constitute a relatively small
group, and because their late hospital death did not appear
to be directly related to the angioplasty procedure, it is
difficult to know whether unsuccessful angioplasty itself
carries an increased hospital mortality.
Our posthospital cardiac mortality rate was 2% during
an average follow-up period of20 months. All three cardiac
deaths were due to severe left ventricular dysfunction. In
contrast, the follow-up mortality rate was approximately 8%
for patients with successful streptokinase therapy and 15%
for patients with unsuccessful streptokinase therapy (27,28).
Reocclusion and restenosis rate. Of the 85 patients in
our series who underwent repeat coronary angiography, 8
(9%) had occlusion of the infarct-related artery. This figure
is comparable with the early reclosure rate noted by Hartzler
et al. (17) and lower than the 31% rate reported by Papa-
pietro et al. (18). Our reocclusion rate is lower than the 20
to 33% rate reported after successful thrombolysis with
streptokinase or with tissue-type plasminogen activator
(2,29,30). Our posthospitalization reinfarction rate was 3%,
with only one of four infarcts due to reocclusion of the
infarct-related artery. In contrast, the reinfarction rate re-
ported by Simoons et al. (6) was 13% for patients with
successful and 6% for patients with unsuccessful strepto-
kinase therapy. Our low rate of reinfarction after successful
angioplasty most likely reflects the importance of alleviating
severe residual stenosis, which is correlated with a high
reocclusion rate (2,14,30).
Restenosis of the infarct-related artery was observed in
31% ofpatients with successful angioplasty who underwent
repeat coronary angiography. Because repeat angiography
was more likely to be performed in patients with recurrent
chest pain after angioplasty, this figure may represent a
slight overestimation of the restenosis rate for the entire
group with successful angioplasty. It is important to note
that 85% of patients with restenosis had a lesion amenable
to repeat angioplasty, and all repeat angioplasty procedures
were successful. Moreover, restenosis was not found in our
study to be associated with either sudden death or acute
reinfarction.
The place of emergency angiopiasty. Emergency an-
gioplasty as primary therapy for acute myocardial infarction
requires the immediate availability of a cardiologist skilled
in angioplasty and a catheterization laboratory team that is
on call 24 hours/day. Under these circumstances, it is pos-
sible to perform angioplasty within I to 3 hours after the
patient arrives in the emergency room. Certainly, in the vast
majority of patients experiencing acute myocardial infarc-
tion, immediate thrombolytic therapy is more available than
emergency angioplasty. Even though intravenous throm-
bolytic therapy often results in restoration of blood flow
within 60 minutes after drug administration, a high grade
residual stenosis that may limit myocardial salvage is usually
present. Additionally, thrombolytic therapy may result in
hemorrhage into ischemic myocardium, which may have a
deleterious effect on ultimate recovery of left ventricular
function. Therefore, the question of whether initial throm-
bolytic therapy followed by angioplasty will yield compa-
rable or better results than emergency angioplasty alone with
respect to myocardial salvage remains to be answered. Fur-
ther clinical trials are necessary to answer these questions
because of the profound cost and manpower impact that
both thrombolytic therapy and emergency angioplasty have
on the treatment of acute myocardial infarction.
Conclusions. Although thrombolytic therapy with agents
such as streptokinase or tissue-type plasminogen activator
has been demonstrated to be effective in restoring blood
flow in acute myocardial infarction, the majority of patients
have significant residual coronary artery stenosis. Because
of the duration of ischemia before reperfusion, the persis-
tence of a high grade coronary artery lesion, or the high
reocclusion rate, myocardial salvage has been difficult to
demonstrate after thrombolytic therapy. Using improvement
in ejection fraction as a measure of myocardial salvage, our
study suggests that emergency percutaneous transluminal
coronary angioplasty is superior to thrombolytic therapy
alone. It remains to be determined whether thrombolytic
therapy followed by angioplasty will yield results superior
to those of emergency angioplasty alone. In contrast to
thrombolytic therapy alone, angioplasty is successful in al-
leviating severe residual stenosis, a factor that we believe
is extremely important in salvaging ischemic myocardium.
Additionally, successful angioplasty may favorably influ-
ence hospital and follow-up mortality in acute myocardial
infarction. In patients who had repeat angiography, partic-
ularly those patients with recurrent angina pectoris, there
was a high restenosis rate. Fortunately, vessels with reste-
nosis were amenable to repeat angioplasty in 85% of cases,
and vessels progressing to total occlusion did so slowly
enough to allow for collateral flow development and to
prevent reinfarction in most cases.
We are indebted to Diane Olson. RN for compilation of the clinical data
and to Teresa Crockett and Carmen Mason for assistance in preparation
of the manuscript.
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